Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02823028 · ClinicalTrials.gov registry record · Phase 2

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)

A Phase 2 study of Smoking Cessation, sponsored by University of California, Irvine.

Completed
Registry status
Phase 2
Development phase
980
Enrollment target
2
Study locations

NCT02823028 is a Phase 2 study of Smoking Cessation that has completed, run by University of California, Irvine. The registered enrollment target is 980 participants, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (109% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02823028, a Phase 2 study of Smoking Cessation, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
Phase 2
Development phase
980 participants
Enrollment target
2
Study locations

Study Summary

Tweet2Quit is an innovative smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging. In a three-group randomized controlled trial, the investigators will compare: 1) usual care, 2) Tweet2Quit-coed, and 3) Tweet2Quit-Women only.

Conditions Studied

Smoking Cessation

Interventions

  • DRUG NRT
  • BEHAVIORAL Web Guide
  • BEHAVIORAL Tweet2Quit

Study Locations (2)

California

  • University of California, Irvine - Paul Merage School of Business - Irvine
  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 980 participants
Start Date 2016-10
Est. Completion 2022-09
Phase Phase 2

Sponsor

University of California, Irvine

368 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02823028

The ClinicalTrials.gov registry entry for NCT02823028 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 980 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (109% higher). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which NRT is the first listed.

NCT02823028 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02823028 about?

NCT02823028 is a clinical study titled "Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)". Tweet2Quit is an innovative smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging. In a three-group randomized controlled trial, the investigators will compare: 1) usual care, 2) Tweet2Quit-coed, and 3) Tweet2Quit-Women only.

What is the current status of trial NCT02823028?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 980 participants. The study started on 2016-10. Estimated completion is 2022-09.

What conditions does trial NCT02823028 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT02823028?

The interventions under investigation include: NRT (DRUG), Web Guide (BEHAVIORAL), Tweet2Quit (BEHAVIORAL).

Who is sponsoring clinical trial NCT02823028?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02823028 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Smoking Cessation

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.